Carlson Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-190,860
Closed -$18.6M 266
2019
Q2
$18.6M Sell
190,860
-8,087
-4% -$738K 0.28% 110
2019
Q1
$18.1M Sell
198,947
-13,571
-6% -$1.21M 0.32% 101
2018
Q4
$19.3M Buy
212,518
+173,801
+449% +$16.2M 0.3% 98
2018
Q3
$3.81M Buy
+38,717
New +$3.58M 0.05% 240
2017
Q3
Sell
-293,800
Closed -$26.1M 246
2017
Q2
$26.1M Buy
+293,800
New +$24.8M 0.37% 84
2016
Q2
Sell
-149,740
Closed -$11.2M 316
2016
Q1
$11.2M Sell
149,740
-12,754
-8% -$961K 0.14% 187
2015
Q4
$12.5M Sell
162,494
-81,561
-33% -$6.14M 0.14% 184
2015
Q3
$16.3M Sell
244,055
-72,226
-23% -$5.32M 0.19% 153
2015
Q2
$23.4M Buy
+316,281
New +$24.2M 0.26% 124
2013
Q3
Sell
-494,220
Closed -$25.4M 303
2013
Q2
$25.4M Buy
+494,220
New +$24.4M 0.31% 111

Other funds holding MDT

Carlson Capital's MDT Position: Q3 2019 in Review

Carlson Capital sold out of Medtronic (MDT) in Q3 2019, closing a stake of 190,860 shares — an estimated $18.6M sold.

Carlson Capital first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $26.1M in Q2 2017. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Carlson Capital reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Carlson Capital sold 190,860 Medtronic shares in Q3 2019, an estimated $18.6M.
  • Carlson Capital first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
  • Carlson Capital's Medtronic position peaked at $26.1M in Q2 2017.
  • 1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Carlson Capital's 13F filing for Q3 2019, filed 13 Nov 2019.